Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Alzheimer's Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01569516
What this trial is testing

Study of Octohydroaminoacridine Succinate Tablets in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Changchun Huayang High-tech Co., Ltd 288
Early research (Phase 1)Study completedNCT01850238
What this trial is testing

Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Axon Neuroscience SE 30
Early research (Phase 1)Study completedNCT05667649
What this trial is testing

Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Regeneration Biomedical, Inc. 7
Early research (Phase 1)WithdrawnNCT03316898
What this trial is testing

A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Allergan
Not applicableStudy completedNCT01796314
What this trial is testing

Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of Life

Who this might be right for
Alzheimer Disease
University Hospital, Toulouse 170
Large-scale testing (Phase 3)Study completedNCT00053599
What this trial is testing

Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study

Who this might be right for
Alzheimer Disease
National Institute on Aging (NIA) 400
Early research (Phase 1)Study completedNCT02434718
What this trial is testing

Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 21
Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Testing effectiveness (Phase 2)Study completedNCT02626572
What this trial is testing

Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms

Who this might be right for
Alzheimer's Disease
Institut de Recherches Internationales Servier 500
Large-scale testing (Phase 3)Temporarily pausedNCT04520412
What this trial is testing

Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. 2,046
Early research (Phase 1)Study completedNCT00736775
What this trial is testing

The Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01009255
What this trial is testing

Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 196
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07205601
What this trial is testing

Study of Intracerebroventricular Injections of Autologous Adipose-Derived Stem Cells (RB-ADSCs) in Participants With Mild-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Regeneration Biomedical, Inc. 115
Not applicableStudy completedNCT04404153
What this trial is testing

Neurostimulation for Cognitive Enhancement in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia
Albert Einstein College of Medicine 100
Early research (Phase 1)Study completedNCT02036645
What this trial is testing

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Who this might be right for
Mild-Moderate Alzheimer's DiseaseHealthy Elderly
AstraZeneca 77
Not applicableUnknownNCT03352739
What this trial is testing

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 30
Early research (Phase 1)Study completedNCT00988598
What this trial is testing

A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Not applicableStudy completedNCT01893398
What this trial is testing

Multistimulation Group Therapy for Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Fondazione Don Carlo Gnocchi ETS 60
Not applicableStudy completedNCT00348309
What this trial is testing

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 1,496
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation